1 / 12Every day we do multiple ways and techniques which promises that it will reduce our obesity. Some tell us to exercise, some tell us to take some kind of medicine. Some even consume expensive herbal products. Now, a successful weight loss drug in America has been launched in India.2 / 12The anti-obesity and anti-diabetic drug Monjaro, manufactured by Eli Lilly and Company, has been approved for sale in India by the CDSCO. The American drug will be marketed under a new name in the Indian market.3 / 12Monjaro is known for its weight loss benefits. Although big doctors say that it not a right way to lose weight, in fact Many doctors have expressed concerns about the side effects of weight loss drugs. However this drug will be a boon for diabetic patients. 4 / 12About 23% of men and 24% of women in India are overweight. This means that India is facing an obesity crisis. This obesity can also lead to many deadly diseases.5 / 12Monjaro, a drug used for type-2 diabetes and obesity, mimics the effects of GLP-1 and GIP, two hormones activated by food intake. By increasing insulin production and reducing appetite, Monjaro effectively controls blood sugar and promotes weight loss. 6 / 12Clinical trials involving 2,539 overweight individuals showed significant weight loss, with an average of 21.8 kg lost by those taking a 15 mg dose and 15.4 kg lost by those taking a 5 mg dose. Over 40 weeks, trials also demonstrated a 2.4% reduction in blood sugar (A1C) levels.7 / 12It was tested on 2,539 overweight people. Those taking the high dose of 15 mg lost an average of 21.8 kg. Those taking the lowest dose of 5 mg lost an average of 15.4 kg.8 / 12Clinical trials conducted over 40 weeks showed that it was effective in reducing blood sugar (A1C) levels by 2.4%.9 / 1210 / 12Means a monthly cost of Rs 14,000 (one injection weekly). A 5 mg injection costs Rs 4,375.11 / 12It has been found to be highly effective and safe in clinical trials. It may take a few weeks or months for weight loss.12 / 12After taking this injection some people may experience nausea, vomiting, constipation, diarrhea, fatigue, or headache.